RARE Grant Program (Research Accelerating RUNX1 Exploration)
The Research Accelerating RUNX1 Exploration Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevention of cancer (before clonal hematopoiesis). The RARE Grant is $250,000 over 2 years (maximum $125,000 per year may be requested).